Ségolène Martin

CEO of techbio company @kantify - AI against rare diseases and cancer

[Ségolène Martin @Segozone]

Look at this smile 🎈

[Eric Topol @EricTopol]

Today "a milestone in the evolution of personalized therapies for rare & ultra-rare inborn errors of metabolism"
—the 1st human to undergo custom genome editing
—outgrowth of decades of NIH funded research
https://t.co/HmJxYWDCV7
https://t.co/4DsNELnBut @NEJM
https://t.co/y7NMGPpXnE

[Eric Topol @EricTopol]

Today "a milestone in the evolution of personalized therapies for rare & ultra-rare inborn errors of metabolism"
—the 1st human to undergo custom genome editing
—outgrowth of decades of NIH funded research
https://t.co/HmJxYWDCV7
https://t.co/4DsNELnBut @NEJM
https://t.co/y7NMGPpXnE

[Hélène Le Borgne @HeleneLBorgne]

Have your say ! Call for evidence for the Biotech Act:
https://t.co/T7T0iOfEHv
The biotech sector plays a critical role in several areas of the EU economy. It is research-driven, fast-moving and requires substantial public and private investments.

[Ségolène Martin @Segozone]

Insightful 🏷️

[Jason Abaluck @Jabaluck]

Good news everyone! The unpopular and seemingly irrelevant lecture I give in my health econ class on "Most favored nations agreements" just became prophetically relevant.

Bad news everyone! This is a terrible policy.
🧵

[Jason Abaluck @Jabaluck]

Good news everyone! The unpopular and seemingly irrelevant lecture I give in my health econ class on "Most favored nations agreements" just became prophetically relevant.

Bad news everyone! This is a terrible policy.
🧵

[Sahil Bloom @SahilBloom]

Everyone needs to hear this…

[Zachary Tracer @ZTracer]

ANY foreign clinical trial site that's part of NIH-funded research may be forced to shut down under new 'America First'-driven policy: https://t.co/Ng1OSGWik9

[NeurIPS Conference @NeurIPSConf]

The NeurIPS 2025 Creative AI Track is now inviting research papers and artworks that explore cutting edge applications of AI and ML in art, design, and creative practice. This year, we welcome submissions on the theme of "Humanity".

Read more in our Call for Creative AI 2025:
https://t.co/wosuzQm26z

[DoctorDueDiligence @DueDoctor]

3. Rare Disease (cited 15 and 72 patients worldwide for example) may get approval based on mechanism of action only - then track and follow patients to see if drug works.

[Paul Graham @paulg]

A smart foreign-born undergrad at a US university asked me if he should go to the UK to start his startup because of the random deportations here. I said that while the median startup wasn't taking things to this extreme yet, it would be an advantage in recruiting.

[Kantify @kantify]

No! This photo is not AI edited: a heart-shaped sun ray appeared right during our last team photo!❤️
Meet below a team of people working every day with a lot of ❤️, talent, and AI - to accelerate the discovery of therapies for patients who need them the most.

[Sam Ghali, M.D. @EM_RESUS]

What’s a life-saving medical fact everyone should know?

[Ségolène Martin @Segozone]

This looks extremely interesting 🤓

[Kantify @kantify]

We are bringing the last touch to our new Behind The Pill release, where we'll share new Sapian predictions. We will focus on the unknown mechanisms of a drug that everyone knows, but is still largely misunderstood.
✉️Be the first to receive it https://t.co/o8nbrVu3HD

[Felipe MIllon @Felipe_Millon]

Today, we at OpenAI launched Deep Researcher and I wanted to share a deeply personal story about how amazing this tool is and how it will change the world. Trigger warning, related to cancer....1/9

[Kantify @kantify]

Hey Twitter, we are disclosing our biotech pipeline, and there is even a bonus for drug discovery experts.
Cancer, Rare Cancers, Rare Neuromuscular disorders, Neurology and Ion Channels are some of our areas of focus.

[Ségolène Martin @Segozone]

@InsermTransfert @CanaudLab @CatherineClusel @DariaJulkowska Bravo 👏

[Kantify @kantify]

Can an AI for human drug discovery also excel in plant drug discovery? The answer is yes!
This is what our COO @Nico_Maignan explained at his lecture "Unlocking & Accelerating Drug Discovery with Artificial Intelligence: The Kantify Approach." held by our partner @IBMCP 🙏🌿

[Oded Rechavi @OdedRechavi]

Scared to share this after 10 freaking years of waiting but here we go: We found that temperature *perception* can change the next generations, even when “it’s just in the parents' head”. Read how C. elegans neurons control epigenetic inheritance! https://t.co/ngjFhb30CR

[Ségolène Martin @Segozone]

Huge randomized trial of AI boosts discovery

“Teams that were randomly assigned to use the tool discovered 44% more new materials and filed 39% more patent applications than did the ones that stuck to their standard workflow”

https://t.co/xHd5ynl5KH

[Kantify @kantify]

Today, we're unveiling the latest small molecule drug screened by our AI, Sapian.
Many of you are familiar with this medication-it was the 169th most prescribed drug in the United States in 2022, with over 3 million prescriptions.
This widely used drug is Diazepam, aka Valium.